Shanghai OPM Biosciences Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shanghai OPM Biosciences Co., Ltd. - overview
Established
2013
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Established in 2013 and based in Shanghai, China, Shanghai OPM Biosciences Co. , Ltd. is a biotechnology company that focuses on developing serum-free media for animal cell culture. The firm also provides full solutions for cell culture.
OPM has established a 2000 square meter GMP-compliant culture media production workshop, a 1500 square meter culture media research and development laboratory and a 4000 square meter CDMO platform in Zhangjiang Science City. The culture media production line has been certified by ISO9001 and ISO13485. The business scope of the company include culture medium solution and end-to-end contract development manufacture organization (CDMO). Its OPM® and Sureness® brands provide customers with total technology plus service solutions to accelerate the process of innovative drugs from genetic (DNA) to clinical filing (IND) to clinical sample production.
The company has also developed chemically defined media and nutritional additives for a wide range of CHO cells, chemically defined media and nutritional additives for HEK293 cells. OPM has served more than 300 customers, such as Jiangsu Hengrui Medicine Co. ,Ltd. , Changchun GeneScience Pharmaceutical Co.
, Ltd. , Hengrui Pharmaceutical, and EpimAb.
Current Investors
Fortune Capital, CCB Private Equity Investment Management, China Renaissance
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Medical Equipment Distributors, Medical Supplies
Website
www.opmbiosciences.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Shanghai OPM Biosciences Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 58,521,000 | 124,970,000 | 212,683,000 | - | - | - |
| % Revenue Growth (YoY) | - | 113.5% | 70.2% | - | - | - |
| EBITDA (USD) | 4,198,000 | 32,431,000 | 105,202,000 | - | - | - |
| Operating Income (USD) | (12,265,000) | 9,855,000 | 64,204,000 | - | - | - |
| Operating Margin | (21.0%) | 7.9% | 30.2% | - | - | - |
| % EBITDA Margin | 7.2% | 26.0% | 49.5% | - | - | - |
| NET Income (USD) | (12,265,000) | 11,684,000 | 60,393,000 | - | - | - |
| % Net Margin | (21.0%) | 9.3% | 28.4% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.